Nippon India Nifty Pharma ETF · Regular · Growth
NAV
₹27.5178
as of 28 Sept 2026
Expense Ratio
—
see scheme documents
AUM
₹1,458 Cr
Lumpsum returns (CAGR)
- 1Y
- +24.87%
- 3Y
- +20.66%
- 5Y
- +13.76%
- Since Inception
- +13.17%
SIP returns (XIRR)
- 1Y
- +27.33%
- 3Y
- +17.57%
- 5Y
- +18.82%
- Since Inception
- +18.40%
What history actually did — last 5 years (Sept 2021 – Sept 2026)
A ₹5,000 monthly SIP for the last 5 years (Sept 2021 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,78,874 today — ₹3,00,000 invested, 19.0% XIRR.
₹3,00,000
Invested
₹4,78,874
Value today
19.0%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Sept 2021 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,89,688 today (13.7% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Sept 2021 would still hold ₹14,18,003.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Sept 2021 – Sept 2026) (3 Jun 2024) would be ₹1,43,481 today (1.44×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised1.00
Sharpe Ratio
—
Alpha
—
Beta
1.03
Sortino
14.01%
Std Dev
-7.53%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Nippon India Nifty Pharma ETF · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
What this fund does
Nippon India Nifty Pharma ETF · Regular · Growth is an exchange-traded fund (ETF) that trades on stock exchanges like a regular share. It offers real-time pricing, low expense ratios, and the flexibility to buy and sell units throughout the trading day.
About This Fund
Nippon India Nifty Pharma ETF · Regular · Growth is a ETF mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 5 years. It manages assets worth ₹1,458 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY PHARMA TRI.
Who Should Invest?
- •Cost-conscious investors who prefer passive investing with low expense ratios